Clinical Efficacy of Recombinant Tissue Plasmin Activator Intravenous Thrombolysis Combined with Butylphthalide in the Treatment of Acute Cerebral Infarction

SHI Guang; LIU Hongzhi; WANG Kun; LU Juan; GU Xuecun

doi:10.14033/j.cnki.cfmr.2023.22.004

Home>Articles>Clinical Efficacy of Recombinant Tissue Plasmin Activator Intravenous Thrombolysis Combined with Butylphthalide in the Treatment of Acute Cerebral Infarction

DOI: 10.14033/j.cnki.cfmr.2023.22.004

Clinical Efficacy of Recombinant Tissue Plasmin Activator Intravenous Thrombolysis Combined with Butylphthalide in the Treatment of Acute Cerebral Infarction

SHI Guang

LIU Hongzhi

WANG Kun

LU Juan

GU Xuecun

Keywords：Acute cerebral infarctionRecombinant tissue plasminogen activatorIntravenous thrombolysisButylphthalideNerve injury markers

Publication Date：2023-08-05

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 13-17 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2023,21(22)